...
首页> 外文期刊>Journal of Clinical Microbiology >Primary Shewanella alga Septicemia in a Patient on Hemodialysis
【24h】

Primary Shewanella alga Septicemia in a Patient on Hemodialysis

机译:血液透析患者原发性希瓦氏菌败血症

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We report the first Japanese case of primary septicemia withShewanella alga and also describe the bacteriological characteristics of and results of antibiotic susceptibility tests of the isolate. S. alga was repeatedly isolated, at times simultaneously with Escherichia coli, from the blood of a 64-year-old female undergoing hemodialysis. The isolated organism was determined to be S. alga based on recently published identification criteria, such as hemolysis on sheep blood agar, no acid production from carbohydrates, and growth on agar containing 6.5% NaCl. Results of antibiotic susceptibility tests demonstrated that the isolate was sensitive to levofloxacin and cefpirome (MICs, ≤0.063) but resistant to cefazolin, ceftizoxime, and imipenem (MICs, >128, 64, and 8 μg/ml, respectively). Although the role of S. alga as a human pathogen has not been fully determined, accumulating data suggest that this organism may be a potential pathogen, especially in compromised hosts.
机译:我们报告了日本首例希瓦氏菌藻的原发性败血病病例,并描述了该菌株的细菌学特征和抗生素敏感性试验结果。 S。从64岁接受血液透析的女性的血液中反复分离藻类,有时与大肠杆菌分离。分离出的生物被确定为 S。 alga 基于最近发布的鉴定标准,例如在羊血琼脂上溶血,从碳水化合物中不产生酸,以及在含6.5%NaCl的琼脂上生长。抗生素药敏试验的结果表明,该分离株对左氧氟沙星和头孢哌酮(MIC,≤0.063)敏感,但对头孢唑啉,头孢唑肟和亚胺培南(MIC,分别> 128、64和8μg/ ml)有抵抗力。虽然 S的作用。藻类作为人类病原体尚未完全确定,积累的数据表明该生物体可能是潜在的病原体,尤其是在受损宿主中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号